Two Sigma Advisers’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.99M | Buy |
|
|||||
|
2025
Q1 | $5.34M | Sell |
|
|||||
|
2024
Q4 | $248M | Sell |
|
|||||
|
2024
Q3 | $491M | Sell |
|
|||||
|
2024
Q2 | $497M | Buy |
|
|||||
|
2024
Q1 | $376M | Buy |
|
|||||
|
2023
Q4 | $87M | Sell |
|
|||||
|
2023
Q3 | $430M | Buy |
|
|||||
|
2023
Q2 | $178M | Buy |
|
|||||
|
2023
Q1 | $68.4M | Buy |
|
|||||
|
2022
Q4 | $77.6M | Sell |
|
|||||
|
2022
Q3 | $130M | Buy |
|
|||||
|
2022
Q2 | $97.4M | Sell |
|
|||||
|
2022
Q1 | $217M | Sell |
|
|||||
|
2021
Q4 | $383M | Buy |
|
|||||
|
2021
Q3 | $43.3M | Sell |
|
|||||
|
2021
Q2 | $422M | Buy |
|
|||||
|
2021
Q1 | $387M | Buy |
|
|||||
|
2020
Q4 | $269M | Sell |
|
|||||
|
2020
Q3 | $369M | Sell |
|
|||||
|
2020
Q2 | $362M | Buy |
|
|||||
|
2020
Q1 | $207M | Sell |
|
|||||
|
2019
Q4 | $449M | Buy |
|
|||||
|
2019
Q3 | $245M | Buy |
|
|||||
|
2019
Q2 | $182M | Buy |
|
|||||
|
2019
Q1 | $109M | Buy |
|
|||||
|
2018
Q4 | $111M | Sell |
|
|||||
|
2018
Q3 | $126M | Sell |
|
|||||
|
2018
Q2 | $144M | Sell |
|
|||||
|
2018
Q1 | $398M | Buy |
|
|||||
|
2017
Q4 | $384M | Buy |
|
|||||
|
2017
Q3 | $352M | Buy |
|
|||||
|
2017
Q2 | $103M | Sell |
|
|||||
|
2017
Q1 | $132M | Buy |
|
|||||
|
2016
Q4 | $77.2M | Buy |
|
|||||
|
2016
Q3 | $26.8M | Buy |
|
|||||
|
2016
Q2 | $27.5M | Sell |
|
|||||
|
2016
Q1 | $192M | Buy |
|
|||||
|
2015
Q4 | $153M | Buy |
|
|||||
|
2015
Q3 | $21.2M | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $12.1M | Sell |
|
|||||
|
2014
Q3 | $20M | Sell |
|
|||||
|
2014
Q2 | $21.3M | Sell |
|
|||||
|
2014
Q1 | $89.4M | Sell |
|
|||||
|
2013
Q4 | $102M | Buy |
|
|||||
|
2013
Q3 | $74.3M | Buy |
|
|||||
|
2013
Q2 | $332K | Buy |
|